The occurrence and kinetics of systemic inflammatory response reflected by serum CRP has been implicated with clinical outcome and treatment response in diverse cancer entities, including urothelial cancer, non‐small‐cell lung cancer and mRCC.9, 10, 11, 12, 13, 14. The gene discussed is CRP; the disease is cancer.